Pharsight

Drugs that contain Clindamycin Phosphate

1. Cleocin patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6495157 PFIZER Intravaginal clindamycin ovule composition
Jul, 2020

(3 years ago)

Market Authorisation Date: 13 August, 1999

Treatment: NA

Dosage: SUPPOSITORY;VAGINAL

More Information on Dosage

CLEOCIN family patents

Family Patents

2. Clindagel patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6387383 BAUSCH Topical low-viscosity gel composition
Aug, 2020

(3 years ago)

Market Authorisation Date: 27 November, 2000

Treatment: Topical treatment of acne vulgaris

Dosage: GEL;TOPICAL

More Information on Dosage

CLINDAGEL family patents

Family Patents

3. Clindesse patents expiration

CLINDESSE Litigations
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5993856 PADAGIS US Pharmaceutical preparations and methods for their administration
Nov, 2017

(6 years ago)

US6899890 PADAGIS US Bioadhesive drug delivery system
Apr, 2023

(11 months ago)

US9789057 PADAGIS US Pharmaceutical delivery system
Dec, 2026

(2 years from now)

Market Authorisation Date: 30 November, 2004

Treatment: Method of treating bacterial vaginosis

Dosage: CREAM;VAGINAL

How can I launch a generic of CLINDESSE before it's drug patent expiration?
More Information on Dosage

CLINDESSE family patents

Family Patents

4. Evoclin patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7374747 MYLAN Pharmaceutical foam
Jan, 2024

(2 months ago)

US7141237 MYLAN Pharmaceutical foam
Feb, 2024

(2 months ago)

Market Authorisation Date: 22 October, 2004

Treatment: Treatment of acne vulgaris

Dosage: AEROSOL, FOAM;TOPICAL

How can I launch a generic of EVOCLIN before it's drug patent expiration?
More Information on Dosage

EVOCLIN family patents

Family Patents

5. Xaciato patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11129896 DARE Topical formulations and treatments
Sep, 2036

(12 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) Dec 07, 2024
Generating Antibiotic Incentives Now(GAIN) Dec 07, 2029

Market Authorisation Date: 07 December, 2021

Treatment: Method of treating bacterial vaginosis by single dose administration of a clindamycin pharmaceutical gel formulation

Dosage: GEL;VAGINAL

More Information on Dosage

XACIATO family patents

Family Patents